Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0601AI06 SSEA-4 positional isomer(d18:1/26:0) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1820.05 C87H157N3O36
LMSP0601AI08 SSEA-4 positional isomer(d18:1/26:1(17Z)) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1818.04 C87H155N3O36
LMSP0601CH01 Sialyl-Lea(d18:1/16:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1663.9 C77H137N3O35
LMSP0601CH02 Sialyl-Lea(d18:1/18:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1691.93 C79H141N3O35
LMSP0601CH03 Sialyl-Lea(d18:1/20:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1719.97 C81H145N3O35
LMSP0601CH04 Sialyl-Lea(d18:1/22:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1748 C83H149N3O35
LMSP0601CH05 Sialyl-Lea(d18:1/24:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1776.03 C85H153N3O35
LMSP0601CH07 Sialyl-Lea(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1774.01 C85H151N3O35
LMSP0601CH06 Sialyl-Lea(d18:1/26:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1804.06 C87H157N3O35
LMSP0601CH08 Sialyl-Lea(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1802.04 C87H155N3O35
LMSP0601FJ01 VIM-II(d18:1/16:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2029.04 C91H160N4O45
LMSP0601FJ02 VIM-II(d18:1/18:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2057.07 C93H164N4O45
LMSP0601FJ03 VIM-II(d18:1/20:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2085.1 C95H168N4O45
LMSP0601FJ04 VIM-II(d18:1/22:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2113.13 C97H172N4O45
LMSP0601FJ05 VIM-II(d18:1/24:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2141.16 C99H176N4O45
LMSP0601FJ07 VIM-II(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2139.15 C99H174N4O45
LMSP0601FJ06 VIM-II(d18:1/26:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2169.19 C101H180N4O45
LMSP0601FJ08 VIM-II(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2167.18 C101H178N4O45
LMSP0601FU01 X3 ganglioside(d18:1/16:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2540.23 C111H193N5O59
LMSP0601FV01 X3 ganglioside(d18:1/16:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2540.23 C111H193N5O59
LMSP0601FU02 X3 ganglioside(d18:1/18:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2568.26 C113H197N5O59
LMSP0601FV02 X3 ganglioside(d18:1/18:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2568.26 C113H197N5O59
LMSP0601FV03 X3 ganglioside(d18:1/20:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2596.29 C115H201N5O59
LMSP0601FU03 X3 ganglioside(d18:1/20:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2596.29 C115H201N5O59
LMSP0601FU04 X3 ganglioside(d18:1/22:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2624.32 C117H205N5O59
LMSP0601FV04 X3 ganglioside(d18:1/22:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2624.32 C117H205N5O59
LMSP0601FV05 X3 ganglioside(d18:1/24:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2652.35 C119H209N5O59
LMSP0601FU05 X3 ganglioside(d18:1/24:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2652.35 C119H209N5O59
LMSP0601FU07 X3 ganglioside(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2650.34 C119H207N5O59
LMSP0601FV07 X3 ganglioside(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2650.34 C119H207N5O59
LMSP0601FV06 X3 ganglioside(d18:1/26:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2680.38 C121H213N5O59
LMSP0601FU06 X3 ganglioside(d18:1/26:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2680.38 C121H213N5O59
LMSP0601FU08 X3 ganglioside(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2678.37 C121H211N5O59
LMSP0601FV08 X3 ganglioside(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2678.37 C121H211N5O59
LMSP0601FW01 X4 ganglioside(d18:1/16:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2686.28 C117H203N5O63
LMSP0601FW02 X4 ganglioside(d18:1/18:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2714.31 C119H207N5O63
LMSP0601FW03 X4 ganglioside(d18:1/20:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2742.35 C121H211N5O63
LMSP0601FW04 X4 ganglioside(d18:1/22:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2770.38 C123H215N5O63
LMSP0601FW05 X4 ganglioside(d18:1/24:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2798.41 C125H219N5O63
LMSP0601FW07 X4 ganglioside(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2796.39 C125H217N5O63
LMSP0601FW06 X4 ganglioside(d18:1/26:0) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2826.44 C127H223N5O63
LMSP0601FW08 X4 ganglioside(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2824.42 C127H221N5O63
LMSP0601EA01 disialyl Lea(d18:1/16:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1955 C88H154N4O43
LMSP0601EA02 disialyl Lea(d18:1/18:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1983.03 C90H158N4O43
LMSP0601EA03 disialyl Lea(d18:1/20:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2011.06 C92H162N4O43
LMSP0601EA04 disialyl Lea(d18:1/22:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2039.09 C94H166N4O43
LMSP0601EA05 disialyl Lea(d18:1/24:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2067.12 C96H170N4O43
LMSP0601EA07 disialyl Lea(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2065.11 C96H168N4O43
LMSP0601EA06 disialyl Lea(d18:1/26:0) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2095.16 C98H174N4O43
LMSP0601EA08 disialyl Lea(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2093.14 C98H172N4O43